Laverock Therapeutics today announces it is to present new data on its innovative gene-silencing platform at the European Society of Gene & Cell Therapy (ESGCT) Conference in Rome 22-25 October.
The UK biotech sector demonstrated encouraging resilience in the third quarter of 2024 raising a total of £808 million in venture capital and public financing. Read our latest report to find out more.
The UK biotech sector secured an impressive £808 million in Q3 2024, defying tough global market conditions and demonstrating sustained investor confidence. Read our latest report to find out more.
This is part of a series of blogs focussing on hearing therapeutics from different sector perspectives. In this blog, Karen Steel shares her thoughts on what she perceives to be some of the biggest opportunities in relation to the development of new treatments for hearing loss.
A new group of MPs and peers, with the support of the BioIndustry Association (BIA), has written to the Chancellor, urging her to protect and promote the UK’s world-leading life sciences sector in the government's first Budget.
eXmoor and Virica receive funding to improve AAV gene therapy manufacturing. Partners will develop formulations of VSEs™ and validate their ability to improve yields of adeno-associated vector (AAVs) at scale, lowering gene therapy costs at commercial scale. Virica and eXmoor will receive advisory services and funding through collaborative Canada-UK government program.
Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announce today they have signed a development agreement that leverages each company’s expertise in cell and gene therapies.
The UK is a global leader in TechBio, drawing substantial investments and nurturing a vibrant ecosystem of talent and businesses, reveals a report launched today by the BIA.
Read the BIA's 2024 TechBio report to learn the current state of the sector and to read case studies from companies on the vanguard of innovation within the field.
Pioneer Group welcomed 425 school children from 29 schools to eight of its sites across the UK this week to mark Ada Lovelace Day, an international celebration of the achievements of women in STEM.
Today marks a pivotal moment for our Association as a key strategic objective has been realised: the new government has placed growth at the centre of its agenda, with life sciences positioned as a cornerstone of that plan.
In this blog, Izzy Webb outlines why the UK has published voluntary guidance to promote synthetic nucleic acid screening and who the guidance is intended for.
In this insightful blog, Louis Taylor, CEO of the British Business Bank, explores how the Mansion House reforms and increased pension fund investments could unlock billions in domestic capital, fueling the next generation of UK innovators.
Symbiosis Pharmaceutical Services Ltd announces the purchase of new premises in Stirling, Scotland, UK. The additional space will double the total footprint of the company across the four facilities that it will operate from, increasing manufacturing capacity by 50% in the short-term.
